VC-backed Inari Medical debuts IPO

Inari Medical, a developer of products that treat patients suffering from venous diseases, has raised about $156 million for its IPO after pricing its over 8.2 million shares at about $19 per share.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this